Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Deseret News Utah Index
Deseret News Composite
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
US Pharmaceuticals Ishares ETF
(NY:
IHE
)
71.86
+0.16 (+0.22%)
Official Closing Price
Updated: 8:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
243,593
Open
71.58
Bid (Size)
70.60 (28)
Ask (Size)
72.88 (27)
Prev. Close
71.70
Today's Range
71.42 - 71.94
52wk Range
55.36 - 72.94
Shares Outstanding
93,000
Dividend Yield
5.02%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
A Look At Pharma ETFs Post Q1 Earnings
May 07, 2024
Pharma ETFs have delivered mixed performances over the past month.
Via
Talk Markets
Topics
ETFs
ETFs To Buy As Eli Lilly Beats Q1 Earnings, Lifts Outlook
May 01, 2024
Eli Lilly and Company posted mixed first-quarter 2024 earnings, beating earnings estimates but lagging on revenues. Investors seeking to tap the opportune moment could bet on ETFs having the largest...
Via
Talk Markets
Topics
ETFs
Performance
YTD
+14.82%
+14.82%
1 Month
+0.20%
+0.20%
3 Month
+5.21%
+5.21%
6 Month
+13.61%
+13.61%
1 Year
+25.11%
+25.11%
More News
Read More
April Showers On Wall Street: Miners, Utilities Emerge As Bright Spots In Gloomy Market
April 30, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
3 Sector ETFs That Beat The Market Last Week
August 14, 2023
Via
Talk Markets
Topics
ETFs
US Pharmaceuticals: A Bifurcated Market
January 12, 2022
Via
Talk Markets
Eli Lilly, Novo Nordisk's Strategies Against New Weight-Loss Drug Competitors
February 26, 2024
Via
Benzinga
A Look At Pharma ETFs After Q4 Earnings
February 12, 2024
Via
Talk Markets
Topics
ETFs
Bank Of America Predicts 10 2024 Market Surprises: From Booming IPOs To Japanese Equity Surge
January 09, 2024
Via
Benzinga
Topics
Bonds
Exposures
Debt Markets
3 Beaten-Down ETFs To Buy For A Turnaround In 2024
December 22, 2023
Via
Talk Markets
Topics
ETFs
Exposures
COVID-19
5 Secret Santa ETFs That Might Surprise You This Christmas
December 16, 2023
Via
Talk Markets
Topics
ETFs
Pharmacy Workers Strike At CVS and Walgreens, Echoing Wider Pharma Sector Unrest
November 05, 2023
Via
Benzinga
5 Sector ETFs That Outperformed in Turbulent August
August 30, 2023
Via
Talk Markets
Topics
ETFs
Q2 Earnings & Market Sell-Off Impact: 5 Must-See ETF Charts
August 25, 2023
Via
Talk Markets
Topics
ETFs
Pharma ETFs in Focus Post Q2 Earnings
August 11, 2023
Via
Talk Markets
Topics
ETFs
3 Biotech Stocks to Sell in June Before They Crash and Burn
June 06, 2023
Via
InvestorPlace
Pharma ETFs Gain Post Q1 Earnings
May 09, 2023
Via
Talk Markets
A Look At Pharma ETFs Post Q4 Earnings
February 08, 2023
Via
Talk Markets
4 Sector ETFs To Watch Ahead Of Mid-Election Results
November 10, 2022
Via
Talk Markets
5 ETFs To Watch After 2022 Midterm Elections: Which Sectors Win From Republican Or Democrat Majority?
November 09, 2022
Via
Benzinga
Pharma ETFs In Focus Post Q3 Earnings
November 09, 2022
Via
Talk Markets
ETF Mid-Year Outlook & Investing Strategies
July 22, 2022
Via
Talk Markets
Wave of Solid Q3 Earnings Push Pharma ETFs Higher
November 09, 2021
Via
Talk Markets
J&J ETFs to Gain on Upbeat COVID-19 Vaccine Data
September 25, 2021
Via
Talk Markets
Exposures
COVID-19
Will Pfizer ETFs Soar on FDA's COVID-19 Vaccine Booster Approval?
September 24, 2021
Via
Talk Markets
Exposures
COVID-19
Product Safety
3 Dividend-Paying Pharmaceutical Stocks to Buy This Summer
June 05, 2021
Via
Talk Markets
Exposures
COVID-19
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.